Concepedia

Pooja Ghatalia

PG

Statistics

Publications

33

Citations

1.5K

H-Index

22

Active since

2013

Affiliations

Fox Chase Cancer Center(Current)

Dana-Farber Cancer Institute

University of Alabama at Birmingham

Temple University Health System

Merck & Co., Inc., Rahway, NJ, USA (United States)

Pooja Ghatalia is an author at Fox Chase Cancer Center specializing in medicine, oncology, and renal cell carcinoma.

ORCID

Publications per year

2013–2025

33

Publications

33

Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma

Pooja Ghatalia, Jennifer Gordetsky, Fengshen Kuo et al. · Journal for ImmunoTherapy of Cancer · 2019 · 176 citations · Full text

, , +17

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Carl Morrison, Sarabjot Pabla, Jeffrey M. Conroy et al. · Journal for ImmunoTherapy of Cancer · 2018 · 151 citations · Full text

, , +17

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

Toni K. Choueiri, Thomas Powles, Katriina Peltola et al. · New England Journal of Medicine · 2024 · 142 citations

, , +17

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

Sarabjot Pabla, Jeffrey M. Conroy, Mary Nesline et al. · Journal for ImmunoTherapy of Cancer · 2019 · 107 citations · Full text

, , +17

Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA

Neeraj Agarwal, Sumanta K. Pal, Andrew W. Hahn et al. · Cancer · 2018 · 101 citations · Full text

, , +17

1–5 of 33